OVERVIEW

International Meeting on Emerging Diseases and Surveillance is organized by International Society for Infectious Diseases (ISID) and will be held from Nov 09 - 12, 2018 at Hilton Vienna, Wien, Austria. The target audience for this medical event is Healthcare professionals including physicians, and veterinarians, public health specialists, epidemiologists, research scientists, environmentalists, biotechnology industry, journalists, and policy makers.

Topics :
• Antimicrobial resistance
• Bioterrorism and biological warfare
• Climate change and ecological factors in disease emergence
• Diseases at the interface of humans, wildlife and other animals
• Diseases of animals
• Ethical issues in emerging diseases and disease surveillance
• Foodborne and waterborne diseases
• Infections related to travel and migration
• Influenza and other respiratory infections
• Innovations in diagnostic tests for emerging diseases
• Innovations in surveillance for non-communicable diseases
• Infections of public health significance
• New approaches to outbreak surveillance and monitoring
• New, emerging and neglected zoonotic diseases
• New pathogen discovery
• Outbreak modeling
• Outbreak response and control
• Public communication of outbreaks and emerging diseases
• Sociopolitical factors in disease emergence
• Vaccines and emergence of vaccine preventable diseases
• Vectorborne diseases

Additional details will be posted as soon as they are available.

KEY DATES

Event Start Date
09 Nov, 2018
Event Start Date
Event End Date
12 Nov, 2018
Event End Date

SPECIALITIES

Infectious Disease

SUGGESTED HOTELS

CONFERENCE VENUE

LocationHilton Vienna
Am Stadtpark 1

RELATED CONFERENCES & LIVE WEBINARS

Aug 21 - 22, 2026 | Singapore, ...

Infectious Disease
More actions
US$149
By American Medical Seminars (AMS),...

Apr 12 - 15, 2027 | Sarasota, Florida,...

Infectious Disease
20 AMA PRA Category 1 Credits™
...
More actions
US$839

Apr 12 - 15, 2027 | Sarasota, Florida,...

Infectious Disease
20 AMA PRA Category 1 Credits™
...
More actions
US$840